I missed the report last night, listened to it this morning. While i am a die hard fan of OCAT, i think ONCE does have some tremendous potential in treating potential diseases that may be similar , but probably different than OCAT. OCAT is the first FDA approved stem cell company , ONCE is on track to be the first FDA approved gene therapy company.
They are in phase 3 with results coming out in mid 2015. I heard about the company about 4 months ago and have been waiting for the IPO. When the debut came , it was on the same day as Shake Shack which took most of the attention that day. Fine with me, I bought it that day and have been holding since.
I think this company has a PPS of 100.00 and beyond. If phase 3 results are good, it could be another ICPT. Just my opinion.
I own much more OCAT, which is uplisting today! I will be holding onto ONCE for some time as well.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM